My Gold Standard Of Dividend Income - 5 Legends You Should Know

Read here for 5 elite income stocks using the Total Portfolio Approach. Learn how active investing and high-conviction picks ...

Research Solutions, Inc. (NASDAQ:RSSS) Q1 2026 Earnings Call Transcript

Q1 2026 Earnings Call Transcript November 13, 2025Research Solutions, Inc. reports earnings inline with expectations.

Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

ORKA-001 Phase 1 results presented at EADV show potential for once-per-year dosing, higher efficacy and off-treatment remission Over $500M cash and equivalents provides runway over one year past three ...

Esperion Reports Third Quarter 2025 Financial Results and Provides Business Update

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

Detailed price information for Eton Pharmaceutcials Inc (ETON-Q) from The Globe and Mail including charting and trades.

Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission – WATERTOWN, Mass., Nov. 12, 2025 (GLOBE ...